The influence of comorbid conditions on the safety profile of infliximab treatment in Japanese patients with rheumatoid arthritis: The post-marketing surveillance trial.

被引：0
|
作者：
Yano, Toshiro
Togo, Masanori
Nogami, Yoshihide
Takeuchi, Tsutomu
Koike, Takao
机构：
[1] Tanabe Seiyaku Co Ltd, Osaka, Japan
[2] Saitama Med Ctr, Dept Internal Med 2, Kawagoe, Saitama, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S426 / S426
页数：1
相关论文
共 50 条
  • [41] Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance
    Kuwana, Masataka
    Sugiyama, Naonobu
    Momohara, Shigeki
    Atsumi, Tatsuya
    Takei, Syuji
    Tamura, Naoto
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Tanigawa, Miki
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    Mimori, Tsuneyo
    Takagi, Michiaki
    MODERN RHEUMATOLOGY, 2024, 34 (02) : 272 - 286
  • [42] Post-marketing safety profile of ezetimibe in black patients
    Lehman, Heidi
    Andrulonis, David
    Adamsons, Ingrid
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S134 - S134
  • [43] Treatment of Comorbid Anxiety and Depression with Escitalopram: Results of a Post-Marketing Surveillance Study
    Laux, G.
    Friede, M.
    Mueller, W. E.
    PHARMACOPSYCHIATRY, 2013, 46 (01) : 16 - 22
  • [44] Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice ― A Post-Marketing Surveillance ―
    Yamada, Norikazu
    Mo, Makoto
    Ohsawa, Ako
    Sato, Motoki
    Umeyama, Michiaki
    Shima, Daisuke
    Nakamura, Mashio
    CIRCULATION JOURNAL, 2024, 88 (02) : 263
  • [45] Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice - A Post-Marketing Surveillance -
    Yamada, Norikazu
    Mo, Makoto
    Ohsawa, Ako
    Sato, Motoki
    Umeyama, Michiaki
    Shima, Daisuke
    Nakamura, Mashio
    CIRCULATION JOURNAL, 2021, 85 (12) : 2201 - +
  • [46] Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post-marketing surveillance
    Uhara, Hisashi
    Tsuchida, Tetsuya
    Kiyohara, Yoshio
    Akamatsu, Ayumi
    Sakamoto, Takahiko
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2022, 49 (09): : 862 - 871
  • [47] Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study
    Ohtsuki, Mamitaro
    Okubo, Yukari
    Saeki, Hidehisa
    Igarashi, Atsuyuki
    Imafuku, Shinichi
    Abe, Masatoshi
    Chaudhari, Siddharth
    Yaguchi, Masafumi
    Emoto, Ayumi
    Morita, Akimichi
    JOURNAL OF DERMATOLOGY, 2024, 51 (07): : 950 - 963
  • [48] Safety and effectiveness of tadalafil in patients with pulmonary arterial hypertension: Japanese post-marketing surveillance data
    Yamazaki, Hiroyoshi
    Kobayashi, Noriko
    Taketsuna, Masanori
    Tajima, Koyuki
    Murakami, Masahiro
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (05) : 963 - 971
  • [49] Clinical safety and efficacy of "filgrastim biosimilar 2" in Japanese patients in a post-marketing surveillance study
    Tamura, Kazuo
    Hashimoto, Kazue
    Nishikawa, Kiyohiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (05) : 363 - 369
  • [50] Celecoxib in the symptomatic treatment of active osteo- or rheumatoid arthritis: results of a post-marketing surveillance study
    Wigand, R
    Wehling, M
    Brauer, HG
    Stridde, E
    Vergin, H
    May, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (21) : 1188 - 1192
12345